| Financial Year |
March 31 2023 |
| Monetary Funds |
932,607,964.66 |
| Held-for-trading Financial Assets |
4,900,624,284.82 |
| Notes Receivable |
1,100,000.00 |
| Accounts Receivable |
1,201,870,835.22 |
| Advances to Suppliers |
8,405,259.75 |
| Other Receivables |
55,260,768.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,989,960.00 |
| Inventories |
2,511,230,806.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
62,000,000.00 |
| Other Current Assets |
1,105,610,591.15 |
| Total Current Assets |
10,778,710,509.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
111,904,575.09 |
| Long-term Equity Investment |
11,323,722,770.69 |
| Investment Properties |
289,729,846.89 |
| Fixed Assetes |
7,905,515,955.43 |
| Under-construction Projects |
209,419,043.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,281,529,790.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,091,217.40 |
| Deferred Income Tax Assets |
188,275,014.66 |
| Other Non-Current Assets |
148,359,094.43 |
| Sub-Total of Non-Current Assets |
69,278,013,701.69 |
| Total Assets |
80,056,724,211.66 |
| Short-Term Loans |
2,478,569,207.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
332,750,000.00 |
| Accounts Payable |
2,464,754,704.18 |
| Accounts Received In Advance |
12,295,016.57 |
| Employee Compensation Payable |
6,531,660.50 |
| Taxes Payable |
412,710,813.01 |
| Interest Payable |
-- |
| Dividend Payable |
100,887,923.39 |
| Other payables |
347,009,393.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,817,663,419.36 |
| Other Current Liabilities |
5,367,251,949.74 |
| Sub-Total of Current Liabilities |
13,332,261,018.04 |
| Long-term Loans |
16,563,234,640.15 |
| Bonds Payable |
9,976,983,114.38 |
| Long-Term Accounts Payable |
71,404,993.74 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
654,195,232.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,357,213,251.07 |
| Total Liabilities |
40,689,474,269.11 |
| Paid-In Capital(Or Share Stock) |
5,037,747,500.00 |
| Capital Surplus |
9,776,409,372.86 |
| Surplus Reserve |
4,019,593,072.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,570,590,184.25 |
| Minority Stockholder's Interest |
6,266,810,129.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
33,100,439,813.04 |
| Owner's Equity（Stockholder's Equity） |
39,367,249,942.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
80,056,724,211.66 |
